SLV213
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SLV213, covering 2023-04-12 to 2025-07-22. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of SLV213 for the Treatment of COVID-19. [Phase 1]